Kopran Ltd

₹ 253 -3.02%

02 May - close price

About

Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide.

The export percentage is about 65% of the total sales.

Key Points

API Vertical (57%) ^[1]
Development, manufacturing, and sale of diverse Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. One of the leaders in Atenolol & one of the major players in Sterile Carbapenems. Their main products are Sterile Carbapenems (36%), Anti-Hypertensive (17%), and Macrolides (~16%). API vertical is operated by WOS Kopran Research Laboratories. ^[2] ^[3]

Website BSE NSE

Market Cap ₹ 1,223 Cr.
Current Price ₹ 253
High / Low ₹ 292 / 140
Stock P/E 49.2
Book Value ₹ 81.3
Dividend Yield 1.18 %
ROCE 9.44 %
ROE 8.07 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company is expected to give good quarter
Company has delivered good profit growth of 45.2% CAGR over last 5 years
Company has been maintaining a healthy dividend payout of 74.9%

Cons

Stock is trading at 3.12 times its book value
Company has a low return on equity of 7.08% over last 3 years.
Earnings include an other income of Rs.10.6 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	56.56	61.96	29.22	56.22	54.57	64.50	71.18	53.62	67.96	80.23	65.86	98.64	82.33
	51.26	54.90	28.70	51.61	51.11	57.82	64.69	47.72	61.86	72.86	65.04	89.94	70.27
Operating Profit	5.30	7.06	0.52	4.61	3.46	6.68	6.49	5.90	6.10	7.37	0.82	8.70	12.06
OPM %	9.37%	11.39%	1.78%	8.20%	6.34%	10.36%	9.12%	11.00%	8.98%	9.19%	1.25%	8.82%	14.65%
	2.52	2.23	2.35	1.97	1.58	2.28	0.17	14.74	1.16	2.07	1.48	5.79	1.29
Interest	0.70	0.54	0.65	0.53	0.98	0.80	0.50	0.61	0.72	0.84	0.95	0.74	1.02
Depreciation	1.05	1.05	1.08	1.09	1.10	1.06	1.08	1.12	1.12	1.09	1.12	1.16	1.17
Profit before tax	6.07	7.70	1.14	4.96	2.96	7.10	5.08	18.91	5.42	7.51	0.23	12.59	11.16
Tax %	28.67%	26.88%	23.68%	23.79%	21.62%	32.82%	25.20%	5.39%	25.46%	26.50%	30.43%	15.25%	23.75%
	4.33	5.64	0.87	3.78	2.32	4.77	3.80	17.89	4.04	5.52	0.15	10.66	8.51
EPS in Rs	1.00	1.30	0.20	0.87	0.54	0.99	0.79	3.71	0.84	1.14	0.03	2.21	1.77
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	199	250	302	326	187	182	154	197	179	223	205	273	327
	177	216	264	294	162	164	145	174	156	193	189	245	298
Operating Profit	22	34	38	32	25	17	9	23	23	30	15	28	29
OPM %	11%	14%	13%	10%	13%	10%	6%	12%	13%	14%	8%	10%	9%
	6	2	6	6	-0	9	8	3	2	10	8	16	11
Interest	10	12	14	13	10	10	7	5	6	4	3	3	4
Depreciation	11	12	12	10	3	3	3	3	3	4	4	4	5
Profit before tax	6	12	17	15	11	13	7	17	16	33	16	37	31
Tax %	-0%	-0%	-0%	-0%	-0%	36%	32%	25%	29%	28%	27%	15%
	6	12	17	15	11	8	5	13	11	23	12	31	25
EPS in Rs	1.58	3.09	4.36	3.77	2.64	1.97	1.09	3.00	2.59	5.43	2.44	6.48	5.15
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	55%	123%	46%

Compounded Sales Growth
10 Years:	1%
5 Years:	12%
3 Years:	15%
TTM:	27%

Compounded Profit Growth
10 Years:	10%
5 Years:	45%
3 Years:	41%
TTM:	-19%

Stock Price CAGR
10 Years:	22%
5 Years:	45%
3 Years:	11%
1 Year:	70%

Return on Equity
10 Years:	7%
5 Years:	7%
3 Years:	7%
Last Year:	8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	39	39	39	41	43	43	43	43	43	43	48	48	48
Reserves	68	80	98	122	145	158	162	175	186	204	331	347	344
Preference Capital	9	9	9	9	9	-0	9	6	-0	-0	-0	-0
	103	102	129	38	33	56	44	44	46	16	37	28	32
	69	71	64	74	57	54	51	56	52	61	48	82	108
Total Liabilities	279	293	329	275	279	311	300	319	327	324	464	506	532
	112	106	103	33	35	39	38	42	43	47	46	47	55
CWIP	-0	1	1	0	0	4	8	7	7	3	3	4	-0
Investments	7	7	7	46	156	157	157	158	158	159	259	260	260
	161	179	219	195	88	110	97	112	119	115	155	195	216
Total Assets	279	293	329	275	279	311	300	319	327	324	464	506	532

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	35	14	2	53	19	4	12	12	10	49	-38	17
	-10	-8	-9	-10	-4	-9	-2	-4	1	-9	-100	10
	-19	-12	7	-43	-15	5	-11	-7	-11	-40	138	-26
Net Cash Flow	6	-7	0	-0	0	-0	-0	-0	-0	0	-0	1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	69	72	66	33	38	77	48	83	86	81	106	112
Inventory Days	101	87	104	24	90	84	119	78	149	73	119	98
Days Payable	120	111	69	63	114	120	115	101	114	106	85	128
Cash Conversion Cycle	50	48	100	-6	14	41	52	60	121	48	139	82
Working Capital Days	60	76	110	145	54	89	105	94	114	86	192	150
ROCE %	7%	11%	11%	12%	10%	10%	5%	9%	8%	14%	6%	9%

Shareholding Pattern

Numbers in percentages

3 Recently

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	43.78%	43.78%	43.78%	44.25%	44.25%	44.25%	44.29%	44.29%	44.49%	44.49%	44.49%	44.49%
	0.16%	0.27%	0.75%	0.53%	0.50%	0.51%	0.34%	0.41%	0.34%	0.39%	0.48%	0.84%
	0.69%	0.46%	0.16%	0.14%	0.13%	0.14%	0.14%	0.14%	0.14%	0.35%	0.14%	1.20%
	55.37%	55.50%	55.31%	55.07%	55.11%	55.09%	55.22%	55.15%	55.03%	54.78%	54.88%	53.47%
No. of Shareholders	40,512	38,195	37,822	39,906	40,883	41,768	42,034	41,567	44,038	53,791	51,636	50,850

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	44.95%	43.78%	43.78%	43.78%	43.78%	44.25%	44.29%	44.49%
	1.06%	0.00%	0.00%	0.00%	0.00%	0.53%	0.41%	0.84%
	2.75%	2.59%	2.90%	2.41%	2.29%	0.14%	0.14%	1.20%
	51.23%	53.63%	53.33%	53.81%	53.93%	55.07%	55.15%	53.47%
No. of Shareholders	31,601	34,329	32,602	31,408	35,833	39,906	41,567	50,850

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

Feb 2024
Transcript PPT
Feb 2024

Transcript

Notes
PPT
Nov 2023
Transcript PPT
May 2022

Transcript

Notes
PPT
Nov 2021

Transcript

Notes
PPT
Jun 2021

Transcript

Notes
PPT
Feb 2021

Transcript

Notes
PPT
Nov 2020

Transcript

Notes
PPT